13 studies were found.

1.		No longer recruiting	Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer Conditions: stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
2.		No longer recruiting	Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; ...
3.		No longer recruiting	Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage III non-small cell lung cancer
4.		No longer recruiting	Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
5.		No longer recruiting	Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; Recurrent Small Cell Lung Cancer; stage IIIB non-small cell lung cancer; Quality of Life
6.		No longer recruiting	Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer Condition: stage IIIB non-small cell lung cancer
7.		No longer recruiting	Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer Condition: stage IIIA non-small cell lung cancer
8.		Completed	Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer Condition: Recurrent Small Cell Lung Cancer
9.		No longer recruiting	Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer
10.		No longer recruiting	Paclitaxel in Treating Patients With Lung Cancer Conditions: stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung
11.		No longer recruiting	Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed Conditions: recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma
12.		No longer recruiting	Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
13.		No longer recruiting	Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Conditions: limited stage small cell lung cancer; Quality of Life